284 related articles for article (PubMed ID: 10698005)
1. Effects of chronic delta9-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment.
Wu X; French ED
Neuropharmacology; 2000 Jan; 39(3):391-8. PubMed ID: 10698005
[TBL] [Abstract][Full Text] [Related]
2. delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors.
French ED
Neurosci Lett; 1997 May; 226(3):159-62. PubMed ID: 9175591
[TBL] [Abstract][Full Text] [Related]
3. Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats.
García-Gil L; Ramos JA; Rubino T; Parolaro D; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1998; 20(5):549-53. PubMed ID: 9761594
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra.
French ED; Dillon K; Wu X
Neuroreport; 1997 Feb; 8(3):649-52. PubMed ID: 9106740
[TBL] [Abstract][Full Text] [Related]
5. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
Varvel SA; Bridgen DT; Tao Q; Thomas BF; Martin BR; Lichtman AH
J Pharmacol Exp Ther; 2005 Jul; 314(1):329-37. PubMed ID: 15831444
[TBL] [Abstract][Full Text] [Related]
6. Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study.
Cheer JF; Marsden CA; Kendall DA; Mason R
Neuroscience; 2000; 99(4):661-7. PubMed ID: 10974429
[TBL] [Abstract][Full Text] [Related]
7. In vitro modulation of the firing rate of dopamine neurons in the rat substantia nigra pars compacta and the ventral tegmental area by antipsychotic drugs.
Werkman TR; Kruse CG; Nievelstein H; Long SK; Wadman WJ
Neuropharmacology; 2001 Jun; 40(7):927-36. PubMed ID: 11378163
[TBL] [Abstract][Full Text] [Related]
8. Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.
Garcia-Gil L; de Miguel R; Romero J; Perez A; Ramos JA; Fernández-Ruiz JJ
Neurotoxicol Teratol; 1999; 21(3):277-83. PubMed ID: 10386831
[TBL] [Abstract][Full Text] [Related]
9. Involvement of subthalamic nucleus in the stimulatory effect of Delta(9)-tetrahydrocannabinol on dopaminergic neurons.
Morera-Herreras T; Ruiz-Ortega JA; Gómez-Urquijo S; Ugedo L
Neuroscience; 2008 Feb; 151(3):817-23. PubMed ID: 18164823
[TBL] [Abstract][Full Text] [Related]
10. Afferent-specific AMPA receptor subunit composition and regulation of synaptic plasticity in midbrain dopamine neurons by abused drugs.
Good CH; Lupica CR
J Neurosci; 2010 Jun; 30(23):7900-9. PubMed ID: 20534838
[TBL] [Abstract][Full Text] [Related]
11. Novel in vivo electrophysiological assay for the effects of cocaine and putative "cocaine antagonists" on dopamine transporter activity of substantia nigra and ventral tegmental area dopamine neurons.
Hinerth MA; Collins HA; Baniecki M; Hanson RN; Waszczak BL
Synapse; 2000 Dec; 38(3):305-12. PubMed ID: 11020233
[TBL] [Abstract][Full Text] [Related]
12. Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation.
Pistis M; Porcu G; Melis M; Diana M; Gessa GL
Eur J Neurosci; 2001 Jul; 14(1):96-102. PubMed ID: 11488953
[TBL] [Abstract][Full Text] [Related]
13. Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain.
Melis M; Gessa GL; Diana M
Prog Neuropsychopharmacol Biol Psychiatry; 2000 Aug; 24(6):993-1006. PubMed ID: 11041539
[TBL] [Abstract][Full Text] [Related]
14. Dorsal raphe stimulation differentially modulates dopaminergic neurons in the ventral tegmental area and substantia nigra.
Gervais J; Rouillard C
Synapse; 2000 Mar; 35(4):281-91. PubMed ID: 10657038
[TBL] [Abstract][Full Text] [Related]
15. Acute and repeated administration of the selective 5-HT(2A) receptor antagonist M100907 significantly alters the activity of midbrain dopamine neurons: an in vivo electrophysiological study.
Minabe Y; Hashimoto K; Watanabe KI; Ashby CR
Synapse; 2001 May; 40(2):102-12. PubMed ID: 11252021
[TBL] [Abstract][Full Text] [Related]
16. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
17. Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.
Hudson R; Renard J; Norris C; Rushlow WJ; Laviolette SR
J Neurosci; 2019 Oct; 39(44):8762-8777. PubMed ID: 31570536
[TBL] [Abstract][Full Text] [Related]
18. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
Adams MD; Chait LD; Earnhardt JT
Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
[TBL] [Abstract][Full Text] [Related]
19. Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: An in vivo electrophysiological study.
Minabe Y; Matsuno K; Ashby CR
Synapse; 1999 Aug; 33(2):129-40. PubMed ID: 10400891
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area.
Bowery B; Rothwell LA; Seabrook GR
Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
